Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.05%
Product Images NDC 72934-2093

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.05% (NDC 72934-2093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E (2 End)

FDA Label Image

V (2093 2 Front)

V (2093 2 Front)
This text appears to be a list of ingredients and measurements for a skincare product. It includes hyaluronic acid sodium salt and tazarotene in specific concentrations, along with a measurement of 30 grams for the product.*
FDA Label Image

X (2093 2 Middle)

X (2093 2 Middle)
This text provides details about the composition of a product with lot number "011314ABCDEFGH@L". The product contains the active ingredients Hyaluronic Acid Sodium Salt at a concentration of 0.5% and Fazzaetene at a concentration of 0.05%. However, there is no information about the intended use of the product. Additionally, the name of an inactive ingredient called "Suspendisse Cream" is also mentioned.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.